Company intelligence / Profile preview

Espoir Therapeutics

Leiden, South Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

Espoir Therapeutics is a biotechnology company based in the Netherlands that specializes in the development of gene therapies for Duchenne Muscular Dystrophy (DMD). The company aims to address the underlying genetic cause of DMD by restoring the production of the dystrophin protein using advanced viral vector technologies. Founded by experts in neuromuscular research, Espoir focuses on creating treatments for patient populations that are not currently served by existing therapies. The company is headquartered at the Leiden Bio Science Park, a hub for life sciences innovation in Europe.

Therapeutic areas: Rare Diseases
Modalities: Gene therapy
Industry: Biotech

Beyond the preview

Go deeper on Espoir Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Espoir Therapeutics.

Explore the full profile